Sleep Disorders Trial, Recruiting NCT06618417 Sponsor: Herlev and Gentofte Hospital Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06618417
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a type of irregular heartbeat called atrial fibrillation (AF), either the kind that comes and goes or the kind that persists over time
  • People who own a compatible smartphone
  • People aged 18 years or older

Who may not be able to join:

  • People who have previously been tested or investigated for sleep-related breathing problems (such as sleep apnoea)
  • People with advanced heart failure where the heart's pumping function is significantly reduced and who experience severe limitations with physical activity
  • People who hold a professional or occupational driver's licence
  • People who are pregnant
  • People currently taking the medications Doxazosin or Terazosin (a type of drug known as alpha-adrenergic antagonists)
  • People who have a condition affecting blood flow in the legs (peripheral arterial disease) that causes daily pain when walking

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +45 22434186

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Herlev and Gentofte Hospital
Registry
ClinicalTrials.gov
Start date
5 December 2024
Est. completion
1 February 2027

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Quality of Life

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov